AUTORIZZAZIONE ALLO SVOLGIMENTO PRESSO LA U.O.C. ONCOLOGIA MEDICA 1 DELL’ISTITUTO REGINA ELENA DELLA SPERIMENTAZIONE DAL TITOLO “REAL-WORLD ACTIVITY AND SAFETY OF PEMBROLIZUMAB-LENVATINIB COMBINATION IN PATIENTS WITH ADVANCED ENDOMETRIAL CANCER IN ITALY- STUDIO REALITY” ED APPROVAZIONE DEL CONTRATTO CON L’ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI RESPONSABILE: Dr.ssa Paola Malaguti R.S. IFO/86/CTIS/24
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Italian
Albanian
Arabic
Bengali
Bulgarian
Chinese (Traditional)
English
Filipino
French
German
Greek
Hindi
Japanese
Polish
Portuguese
Romanian
Russian
Slovenian
Spanish
Ukrainian